Trial Profile
A Randomized, Double-blind, Double-dummy, Parallel Group, Single-center Study Evaluating the Analgesic Effect of Single Doses of Lumiracoxib 400 mg, Celecoxib 400 mg and Placebo in the Treatment of Post-dental Surgery Pain.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Lumiracoxib (Primary) ; Celecoxib
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Novartis
- 12 Dec 2009 New trial record.
- 01 Jan 2008 Results have been reported in The Journal of Pain.